Breast cancer has three major subtypes: human epidermal growth factor 2 positive (HER2+) (70% of patients), HER2- (15–20%), and triple-negative (tumors lacking all three standard molecular markers; 15%) [4]. The gene discussed is ERBB2; the disease is breast cancer.